Update on new GH-IGF axis genetic defects

Carregando...
Imagem de Miniatura
Citações na Scopus
12
Tipo de produção
article
Data de publicação
2019
Título da Revista
ISSN da Revista
Título do Volume
Editora
SBEM-SOC BRASIL ENDOCRINOLOGIA & METABOLOGIA
Citação
ARCHIVES OF ENDOCRINOLOGY METABOLISM, v.63, n.6, p.608-617, 2019
Projetos de Pesquisa
Unidades Organizacionais
Fascículo
Resumo
The somatotropic axis is the main hormonal regulator of growth. Growth hormone (GH), also known as somatotropin, and insulin-like growth factor 1 (IGF-1) are the key components of the somatotropic axis. This axis has been studied for a long time and the knowledge of how some molecules could promote or impair hormones production and action has been growing over the last decade. The enhancement of large-scale sequencing techniques has expanded the spectrum of known genes and several other candidate genes that could affect the GH-IGF1-bone pathway. To date, defects in more than forty genes were associated with an impairment of the somatotropic axis. These defects can affect from the secretion of GH to the bioavailability and action of IGF-1. Affected patients present a large heterogeneous group of conditions associated with growth retardation. In this review, we focus on the description of the GH-IGF axis genetic defects reported in the last decade.
Palavras-chave
Growth hormone, short stature, IGF, somatotropic axis
Referências
  1. AMSELEM S, 1989, NEW ENGL J MED, V321, P989, DOI 10.1056/NEJM198910123211501
  2. Argente J, 2018, GROWTH HORM IGF RES, V40, P17, DOI 10.1016/j.ghir.2018.04.001
  3. Arnhold IJP, 2015, J MOL ENDOCRINOL, V54, pR141, DOI 10.1530/JME-15-0009
  4. Bae GU, 2011, AM J HUM GENET, V89, P231, DOI 10.1016/j.ajhg.2011.07.001
  5. Bashamboo A, 2016, J CLIN ENDOCR METAB, V101, P12, DOI 10.1210/jc.2015-2995
  6. Batey L, 2014, J CLIN ENDOCR METAB, V99, pE153, DOI 10.1210/jc.2013-3106
  7. Begemann M, 2015, NEW ENGL J MED, V373, P349, DOI 10.1056/NEJMoa1415227
  8. Chudasama KK, 2013, AM J HUM GENET, V93, P150, DOI 10.1016/j.ajhg.2013.05.023
  9. Conover CA, 2011, ENDOCRINOLOGY, V152, P2837, DOI 10.1210/en.2011-0036
  10. Correa FA, 2019, ARCH ENDOCRIN METAB, V63, P167, DOI 10.20945/2359-3997000000139
  11. Correa FA, 2018, CLIN ENDOCRINOL, V88, P425, DOI 10.1111/cen.13535
  12. Correa FA, 2015, ENDOCR CONNECT, V4, P100, DOI 10.1530/EC-15-0015
  13. Dauber A, 2016, EMBO MOL MED, V8, P363, DOI 10.15252/emmm.201506106
  14. Dauber A, 2014, J CLIN ENDOCR METAB, V99, P3080, DOI 10.1210/jc.2014-1506
  15. DOLLE P, 1990, CELL, V60, P809, DOI 10.1016/0092-8674(90)90095-V
  16. Dyment DA, 2013, AM J HUM GENET, V93, P158, DOI 10.1016/j.ajhg.2013.06.005
  17. Fang Q, 2016, ENDOCR REV, V37, P636, DOI 10.1210/er.2016-1101
  18. Flanagan SE, 2014, NAT GENET, V46, P812, DOI 10.1038/ng.3040
  19. Franca MM, 2010, J CLIN ENDOCR METAB, V95, pE384, DOI 10.1210/jc.2010-1050
  20. Fuqua JS, 2012, HORM RES PAEDIAT, V78, P59, DOI 10.1159/000337249
  21. Gaston-Massuet C, 2016, P NATL ACAD SCI USA, V113, pE548, DOI 10.1073/pnas.1503346113
  22. Gutierrez M, 2018, MOL CELL ENDOCRINOL, V473, P166, DOI 10.1016/j.mce.2018.01.016
  23. Habib WA, 2018, GENET MED, V20, P250, DOI 10.1038/gim.2017.105
  24. Hong MI, 2012, PLOS GENET, V8, DOI 10.1371/journal.pgen.1002999
  25. Hwa V, 1999, ENDOCR REV, V20, P761, DOI 10.1210/er.20.6.761
  26. Hwa V, 2016, GROWTH HORM IGF RES, V28, P16, DOI 10.1016/j.ghir.2015.12.006
  27. Johnston JJ, 2010, HUM MUTAT, V31, P1142, DOI 10.1002/humu.21328
  28. JONES JI, 1995, ENDOCR REV, V16, P3, DOI 10.1210/er.16.1.3
  29. Karaca E, 2015, J CLIN ENDOCR METAB, V100, pE140, DOI 10.1210/jc.2014-1984
  30. Kietzman HW, 2014, PLOS ONE, V9, DOI 10.1371/journal.pone.0089448
  31. Klammt J, 2018, NAT COMMUN, V9, DOI 10.1038/s41467-018-04521-0
  32. Kofoed EM, 2003, NEW ENGL J MED, V349, P1139, DOI 10.1056/NEJMoa022926
  33. Laron Z, 2004, J CLIN ENDOCR METAB, V89, P1031, DOI 10.1210/jc.2003-031033
  34. Lee CK, 2002, IMMUNITY, V17, P63, DOI 10.1016/S1074-7613(02)00336-9
  35. Liu DG, 2017, FRONT GENET, V8, DOI 10.3389/fgene.2017.00105
  36. McCabe MJ, 2011, J CLIN ENDOCR METAB, V96, pE1709, DOI 10.1210/jc.2011-0454
  37. Milner JD, 2015, BLOOD, V125, P591, DOI 10.1182/blood-2014-09-602763
  38. PHILLIPS JA, 1981, P NATL ACAD SCI-BIOL, V78, P6372, DOI 10.1073/pnas.78.10.6372
  39. Pinto G, 1997, J CLIN ENDOCR METAB, V82, P3450, DOI 10.1210/jc.82.10.3450
  40. Poulton C, 2018, AM J MED GENET A, V176, P2561, DOI 10.1002/ajmg.a.40502
  41. Raivio T, 2012, J CLIN ENDOCR METAB, V97, pE694, DOI 10.1210/jc.2011-2938
  42. Ranke MB, 2018, NAT REV ENDOCRINOL, V14, P285, DOI 10.1038/nrendo.2018.22
  43. Rockstroh D, 2019, EUR J ENDOCRINOL, V180, pK1, DOI 10.1530/EJE-18-0601
  44. Scalco RC, 2015, EUR J ENDOCRINOL, V173, P291, DOI 10.1530/EJE-15-0398
  45. Sediva H, 2017, HORM RES PAEDIAT, V88, P160, DOI 10.1159/000456544
  46. Snell GD, 1929, P NATL ACAD SCI USA, V15, P274, DOI 10.1073/pnas.15.3.274
  47. Strande NT, 2017, AM J HUM GENET, V100, P895, DOI 10.1016/j.ajhg.2017.04.015
  48. Sun Y, 2012, NAT GENET, V44, P1375, DOI 10.1038/ng.2453
  49. Takagi M, 2015, EUR J ENDOCRINOL, V172, DOI 10.1530/EJE-14-0255
  50. Tatsi C, 2013, J CLIN ENDOCR METAB, V98, pE779, DOI 10.1210/jc.2012-3982
  51. TATSUMI K, 1992, NAT GENET, V1, P56, DOI 10.1038/ng0492-56
  52. Thauvin-Robinet C, 2013, AM J HUM GENET, V93, P141, DOI 10.1016/j.ajhg.2013.05.019
  53. Vairamani K, 2017, J ENDOCR SOC, V1, P345, DOI 10.1210/js.2016-1119
  54. van Duyvenvoorde HA, 2010, J CLIN ENDOCR METAB, V95, pE363, DOI 10.1210/jc.2010-0511
  55. Wakeling EL, 2017, NAT REV ENDOCRINOL, V13, P105, DOI 10.1038/nrendo.2016.138
  56. Walenkamp MJE, 2019, J CLIN ENDOCR METAB, V104, P3157, DOI 10.1210/jc.2018-02065
  57. Wang J, 2004, J ENDOCRINOL, V180, P247, DOI 10.1677/joe.0.1800247
  58. Waters MJ, 2011, HORM RES PAEDIAT, V76, P12, DOI 10.1159/000329138
  59. Webb EA, 2013, BRAIN, V136, P3096, DOI 10.1093/brain/awt218
  60. Woods KA, 1996, NEW ENGL J MED, V335, P1363, DOI 10.1056/NEJM199610313351805
  61. Yamoto K, 2017, HUM MUTAT, V38, P953, DOI 10.1002/humu.23253
  62. Zwaveling-Soonawala N, 2018, J CLIN ENDOCR METAB, V103, P415, DOI 10.1210/jc.2017-01660